Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

82.27
Delayed Data
As of Jun 29
 -0.04 / -0.05%
Today’s Change
77.92
Today|||52-Week Range
120.37
-18.70%
Year-to-Date
3 Biotech Stocks to Buy on Sale Right Now
Jun 29 / MotleyFool.com - Paid Partner Content
The FDA Unsurprisingly Approves Gilead's New Hepatitis C Drug. Now What?
Jun 28 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Gilead Gets FDA Nod for HCV Drug, Regulus Hit by Clinical Hold
Jun 29 / Zacks.com - Paid Partner Content
Why Gilead (GILD) Stock Is Gaining Today
Jun 28 / TheStreet.com - Paid Partner Content
Top 6 Research Reports for June 29, 2016
Jun 29 / Zacks.com - Paid Partner Content
Instant Analysis: Gilead Sciences Wins an Important FDA Approval
Jun 28 / MotleyFool.com - Paid Partner Content
How Much Will the Elections Affect Healthcare Stocks?
Jun 29 / MotleyFool.com - Paid Partner Content
Why Is Gilead Sciences (GILD) Stock Gaining Today?
Jun 28 / Zacks.com - Paid Partner Content
8 Beaten-Down Post-Brexit Bargains
Jun 29 / TheStreet.com - Paid Partner Content
This Leading Indicator Suggests the Stock Market May Be on the Precipice of Tumbling
Jun 28 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close82.31
Today’s open83.39
Day’s range81.75 - 83.46
Volume10,452,557
Average volume (3 months)10,287,814
Market cap$109.6B
Dividend yield2.29%
Data as of 4:00pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-4.19%
Earnings growth (next 5 years)-1.20%
Revenue growth (last year)+28.71%
P/E ratio7.0
Price/Sales4.80
Price/Book6.32

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+1.68+1.13%
BIIBBiogen+10.39+4.55%
BAXBaxter International...+1.44+3.32%
JUNOJuno Therapeutics In...+0.62+1.59%
Data as of 4:01pm ET, 06/29/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$2.99
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts

Partner Offers

Search for Jobs